Amundi Has $141.40 Million Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Amundi trimmed its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 21.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,433 shares of the medical instruments supplier’s stock after selling 31,084 shares during the quarter. Amundi’s holdings in Mettler-Toledo International were worth $141,395,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in MTD. Proficio Capital Partners LLC acquired a new position in Mettler-Toledo International during the 4th quarter worth approximately $163,216,000. Seilern Investment Management Ltd acquired a new position in Mettler-Toledo International in the 4th quarter valued at approximately $89,221,000. AustralianSuper Pty Ltd increased its position in Mettler-Toledo International by 3,183.2% in the 4th quarter. AustralianSuper Pty Ltd now owns 71,673 shares of the medical instruments supplier’s stock valued at $87,705,000 after acquiring an additional 69,490 shares during the period. Canoe Financial LP increased its position in Mettler-Toledo International by 576.5% in the 4th quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock valued at $67,936,000 after acquiring an additional 47,311 shares during the period. Finally, Principal Financial Group Inc. increased its position in Mettler-Toledo International by 13.9% in the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after acquiring an additional 33,456 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on MTD shares. Citigroup decreased their price target on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Robert W. Baird upped their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Finally, Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,380.50.

Mettler-Toledo International Trading Up 0.4 %

MTD opened at $1,296.16 on Tuesday. The company’s fifty day moving average price is $1,295.29 and its two-hundred day moving average price is $1,322.43. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93. The company has a market cap of $27.11 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, equities analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Gerry Keller sold 600 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now owns 6 shares in the company, valued at $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Christian Magloth sold 790 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. This represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.